Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria

References

• VincentJLRelloJMarshallJInternational study of the prevalence and outcomes of infection in intensive care unitsJAMA2009302212323232919952319
   PubMed Web of Science ®Google Scholar
• TimsitJFLauplandKBUpdate on bloodstream infections in ICUsCurr Opin Crit Care201218547948622820156
   PubMed Web of Science ®Google Scholar
• AmmerlaanHHarbarthSBuitingASecular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infectionClinical Infect Dis201356679880523223600
   PubMed Web of Science ®Google Scholar
• MagiorakosAPSrinivasanACareyRMultidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClin Microbiol Infect201218326828121793988
   PubMed Web of Science ®Google Scholar
• CarletJCollignonPGoldmannDSociety’s failure to protect a precious resource: antibioticsLancet2011378978836937121477855
   PubMed Web of Science ®Google Scholar
• RetamarPPortilloMMLópez-PrietoMDImpact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysisAntimicrob Agents Chemother201256147247822005999
   PubMed Web of Science ®Google Scholar
• ZarkotouOPournarasSTseliotiPPredictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatmentClin Microbiol Infect201117121798180321595793
   PubMed Web of Science ®Google Scholar
• KangCIKimSHParkWBBloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcomeAntimicrob Agents Chemother200549276076615673761
   PubMed Web of Science ®Google Scholar
• JungJYParkMSKimSERisk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unitBMC Infect Dis20101022820670453
   PubMed Web of Science ®Google Scholar
• TabahAKoulentiDLauplandKCharacteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort StudyIntensive Care Med201238121930194523011531
   PubMed Web of Science ®Google Scholar
• Rodríguez-BañoJLópez-PrietoMDPortilloMMEpidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitalsClin Microbiol Infect20101691408141319845694
   PubMed Web of Science ®Google Scholar
• KollefMHZilberbergMDShorrAFEpidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort studyJ Infect201162213013521195110
   PubMed Web of Science ®Google Scholar
• VallésJAlvarez-LermaFPalomarMHealth-care-associated bloodstream infections at admission to the ICUChest2011139481081521106655
   PubMed Web of Science ®Google Scholar
• McDonaldJRFriedmanNDStoutJESextonDJKayeKSRisk factors for ineffective therapy in patients with bloodstream infectionArch Intern Med2005165330831315710794
   PubMedGoogle Scholar
• TimsitJFSoubirouJFVoiriotGTreatment of bloodstream infections in ICUsBMC Infect Dis20141448925431091
   PubMed Web of Science ®Google Scholar
• OkekeINEdelmanRDissemination of antibiotic-resistant bacteria across geographic bordersClin Infect Dis200133336436911438903
   PubMed Web of Science ®Google Scholar
• Al NaiemiNDuimBSavelkoulPHWidespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiologyJ Clin Microbiol20054394862486416145160
   PubMed Web of Science ®Google Scholar
• AyliffeGThe progressive intercontinental spread of methicillin-resistant Staphylococcus aureusClin Infect Dis199724Suppl 1S74S798994782
   PubMed Web of Science ®Google Scholar
• MonteroJGLermaFÁGalleymorePRCombatting resistance in intensive care: the multimodal approach of the Spanish ICU “Zero Resistance” programCrit Care20151911425880421
   PubMed Web of Science ®Google Scholar
• CortegianiARussottoVCapuanoPUse of Cepheid Xpert Carba-R® for rapid detection of carbapenemase-producing bacteria in critically ill, abdominal surgical patients: first report of an observational studyCrit Care201519Suppl 110825881121
   PubMed Web of Science ®Google Scholar
• PronovostPNeedhamDBerenholtzSAn intervention to decrease catheter-related bloodstream infections in the ICUN Engl J Med2006355262725273217192537
   PubMed Web of Science ®Google Scholar
• BerenholtzSMPronovostPJLipsettPAEliminating catheter-related bloodstream infections in the intensive care unitCrit Care Med200432102014202015483409
   PubMed Web of Science ®Google Scholar
• FridkinSKPearSMWilliamsonTHGalgianiJNJarvisWRThe role of understaffing in central venous catheter-associated bloodstream infectionInfect Control Hosp Epidemiol19961731501588708352
   PubMed Web of Science ®Google Scholar
• ElemamARahimianJMandellWInfection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literatureClin Infect Dis200949227127419527172
   PubMed Web of Science ®Google Scholar
• Ben-DavidDKordevaniRKellerNOutcome of carbapenem resistant Klebsiella pneumoniae bloodstream infectionsClin Microbiol Infect2012181546021722257
   PubMed Web of Science ®Google Scholar
• JohnsonMTReichleyRHoppe-BauerJDunneWMMicekSKollefMImpact of previous antibiotic therapy on outcome of Gram-negative severe sepsisCrit Care Med20113981859186521499086
   PubMed Web of Science ®Google Scholar
• MarschallJFraserVJDohertyJWarrenDKBetween community and hospital: healthcare-associated Gram-negative bacteremia among hospitalized patientsInfect Control Hosp Epidemiol200930111050105619803723
   PubMed Web of Science ®Google Scholar
• ShihMJLeeNYLeeHCRisk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control studyJ Microbiol Immunol Infect200841211812318473098
   PubMedGoogle Scholar
• JangTNLeeSHHuangCHLeeCLChenWYRisk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control studyJ Hosp Infect200973214315019716203
   PubMed Web of Science ®Google Scholar
• ThomasJKForrestABhavnaniSMPharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapyAntimicrob Agents Chemother19984235215279517926
   PubMed Web of Science ®Google Scholar
• HatcherJDhillonRAzadianBSAntibiotic resistance mechanisms in the intensive care unitJ Intensive Care Soc2012134297303
   Google Scholar
• OlaitanAOMorandSRolainJMMechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteriaFront Microbiol2014564325505462
   PubMed Web of Science ®Google Scholar
• LivermoreDMMultiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?Clin Infect Dis200234563464011823954
   PubMed Web of Science ®Google Scholar
• UttleyACCollinsCNaidooJGeorgeRVancomycin-resistant enterococciLancet1988331857557582891921
   PubMed Web of Science ®Google Scholar
• ElsnerHASobottkaIMackDLaufsRClaussenMWirthRVirulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolatesEur J Clin Microbiol Infect Dis2000191394210706178
   PubMed Web of Science ®Google Scholar
• AriasCMurrayBEmergence and management of drug-resistant enterococcal infectionsExpert Rev Anti Infect Ther20086563765518847403
   PubMed Web of Science ®Google Scholar
• HollenbeckBLRiceLBIntrinsic and acquired resistance mechanisms in enterococcusVirulence20123542143323076243
   PubMed Web of Science ®Google Scholar
• ShankarNBaghdayanASGilmoreMSModulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalisNature2002417689074675012066186
   PubMed Web of Science ®Google Scholar
• Van WamelWJHendrickxAPBontenMJTopJPosthumaGWillemsRJGrowth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formationInfect Immun200775292493117118984
   PubMed Web of Science ®Google Scholar
• LeclercqREpidemiological and resistance issues in multidrug-resistant staphylococci and enterococciClin Microbiol Infect2009153224223119335370
   PubMed Web of Science ®Google Scholar
• LowyFStaphylococcus aureus infectionsN Engl J Med199833985205329709046
   PubMed Web of Science ®Google Scholar
• ChambersHFDeLeoFRWaves of resistance: Staphylococcus aureus in the antibiotic eraNat Re Microbiol200979629641
   PubMed Web of Science ®Google Scholar
• CostertonJStewartPSGreenbergEBacterial biofilms: a common cause of persistent infectionsScience199928454181318132210334980
   PubMed Web of Science ®Google Scholar
• KatayamaYItoTHiramatsuKA new class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureusAntimicrob Agents Chemother20004461549155510817707
   PubMed Web of Science ®Google Scholar
• UtsuiYYokotaTRole of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureusAntimicrob Agents Chemother19852833974033878127
   PubMed Web of Science ®Google Scholar
• GeraciDBonuraCGiuffrèMtst1-Positive ST22-MRSA-IVa in healthy Italian preschool childrenInfection201442353553824448875
   PubMed Web of Science ®Google Scholar
• Lamaro-CardosoJde LencastreHKipnisAMolecular epidemiology and risk factors for nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in infants attending day care centers in BrazilJ Clin Microbiol200947123991399719828745
   PubMed Web of Science ®Google Scholar
• AppelbaumPCReduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)Int J Antimicrob Agents200730539840817888634
   PubMed Web of Science ®Google Scholar
• PatersonDLResistance in gram-negative bacteria: EnterobacteriaceaeAm J Med20061196 Suppl 1S20S2816735147
   PubMed Web of Science ®Google Scholar
• PitoutJDLauplandKBExtended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernLancet Infect Dis20088315916618291338
   PubMed Web of Science ®Google Scholar
• HawserSPBouchillonSKHobanDJBadalREHsuehPRPatersonDLEmergence of high levels of extended-spectrum-β-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007Antimicrob Agents Chemother20095383280328419506060
   PubMed Web of Science ®Google Scholar
• BushKJacobyGAMedeirosAAA functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrob Agents Chemother1995396121112337574506
   PubMed Web of Science ®Google Scholar
• HallBGBarlowMRevised Ambler classification of β-lactamasesJ Antimicrob Chemother20055561050105115872044
   PubMed Web of Science ®Google Scholar
• TumbarelloMVialePViscoliCPredictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapyClin Infect Dis201255794395022752516
   PubMed Web of Science ®Google Scholar
• NordmannPCuzonGNaasTThe real threat of Klebsiella pneumoniae carbapenemase-producing bacteriaLancet Infect Dis20099422823619324295
   PubMed Web of Science ®Google Scholar
• MatarGCuzonGArajGOxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from LebanonClin Microbiol Infect200814988788818844693
   PubMed Web of Science ®Google Scholar
• CuzonGNaasTBogaertsPGlupczynskiYHuangTDNordmannPPlasmid-encoded carbapenem-hydrolyzing β-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from BelgiumAntimicrob Agents Chemother20085293463346418644970
   PubMed Web of Science ®Google Scholar
• YigitHQueenanAMAndersonGJNovel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniaeAntimicrob Agents Chemother20014541151116111257029
   PubMed Web of Science ®Google Scholar
• ZhangRYangLCaiJCZhouHWChenGXHigh-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expressionJ Med Microbiol200857333233718287296
   PubMed Web of Science ®Google Scholar
• PodschunRUllmannUKlebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factorsClin Microbiol Rev19981145896039767057
   PubMed Web of Science ®Google Scholar
• GutuADSgambatiNStrasbourgerPPolymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systemsAntimicrob Agents Chemother20135752204221523459479
   PubMed Web of Science ®Google Scholar
• MezzatestaMGonaFCaioCOutbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitalsClin Microbiol Infect20111791444144721668577
   PubMed Web of Science ®Google Scholar
• MamminaCBonuraCDi BernardoFOngoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011Euro Surveill2012173314
   Google Scholar
• VelkovTDerisZZHuangJXSurface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniaeInnate Immun201420435036323887184
   PubMed Web of Science ®Google Scholar
• ChengHYChenYFPengHLMolecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43J Biomed Sci2010176020653976
   PubMed Web of Science ®Google Scholar
• CannatelliAD’AndreaMMGianiTIn vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulatorAntimicrob Agents Chemother201357115521552623979739
   PubMed Web of Science ®Google Scholar
• OlaitanAODieneSMKempfMWorldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular studyInt J Antimicrob Agents201444650050725264127
   PubMed Web of Science ®Google Scholar
• CarletJMainardiJLAntibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin?Clin Microbiol Infect20121811322168319
   PubMed Web of Science ®Google Scholar
• KaperJBNataroJPMobleyHLPathogenic Escherichia coliNat Rev Microbiol20042212314015040260
   PubMed Web of Science ®Google Scholar
• LivermoreDMHopeRBrickGLillieMReynoldsRNon-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001–2006J Antimicrob Chemother200862Suppl 2ii41ii5418819979
   PubMedGoogle Scholar
• HöjgårdSAntibiotic resistance – why is the problem so difficult to solve?Infect Ecol Epidemiol2012218165
   PubMedGoogle Scholar
• SoléMPitartCRocaIFirst description of an Escherichia coli strain producing NDM-1 carbapenemase in SpainAntimicrob Agents Chemother20115594402440421730115
   PubMed Web of Science ®Google Scholar
• NummilaKKilpeläinenIZähringerUVaaraMHelanderIMLipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid AMol Microbiol19951622712787565089
   PubMed Web of Science ®Google Scholar
• SandersWSandersCCEnterobacter spp.: pathogens poised to flourish at the turn of the centuryClin Microbiol Rev19971022202419105752
   PubMed Web of Science ®Google Scholar
• MezzatestaMLGonaFStefaniSEnterobacter cloacae complex: clinical impact and emerging antibiotic resistanceFuture Microbiol20127788790222827309
   PubMed Web of Science ®Google Scholar
• KramerASchwebkeIKampfGHow long do nosocomial pathogens persist on inanimate surfaces? A systematic reviewBMC Infect Dis2006613016914034
   PubMed Web of Science ®Google Scholar
• VilaJMartíSSánchez-CéspedesJPorins, efflux pumps and multi-drug resistance in Acinetobacter baumanniiJ Antimicrob Chemother20075961210121517324960
   PubMed Web of Science ®Google Scholar
• Joly-GuillouMLClinical impact and pathogenicity of AcinetobacterClin Microbiol Infect2005111186887316216100
   PubMed Web of Science ®Google Scholar
• QueenanAMBushKCarbapenemases: the versatile β-lactamasesClin Microbiol Rev200720344045817630334
   PubMed Web of Science ®Google Scholar
• PoirelLNordmannPCarbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiologyClin Microbiol Infect200612982683616882287
   PubMed Web of Science ®Google Scholar
• PotronAPoirelLNordmannPEmerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiologyInt J Antimicrob Agents201545656858525857949
   PubMed Web of Science ®Google Scholar
• RuzinAKeeneyDBradfordPAAdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complexJ Antimicrob Chemother20075951001100417363424
   PubMed Web of Science ®Google Scholar
• BonomoRASzaboDMechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosaClin Infect Dis200643Suppl 2S49S5616894515
   PubMed Web of Science ®Google Scholar
• AdamsMDNickelGCBajaksouzianSResistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component systemAntimicrob Agents Chemother20095393628363419528270
   PubMed Web of Science ®Google Scholar
• MoffattJHHarperMHarrisonPColistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide productionAntimicrob Agents Chemother201054124971497720855724
   PubMed Web of Science ®Google Scholar
• FothergillJLWinstanleyCJamesCENovel therapeutic strategies to counter Pseudomonas aeruginosa infectionsExpert Rev Anti Infect Ther201210221923522339195
   PubMed Web of Science ®Google Scholar
• AdairFWGefticSGGelzerJResistance of Pseudomonas to quaternary ammonium compounds. I. Growth in benzalkonium chloride solutionAppl Microbiol19691832993024984761
   PubMedGoogle Scholar
• LivermoreDMWoodfordNThe β-lactamase threat in Enterobacteriaceae, Pseudomonas and AcinetobacterTrends Microbiol200614941342016876996
   PubMed Web of Science ®Google Scholar
• VahabogluHOztürkRAygünGWidespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter studyAntimicrob Agents Chemother19974110226522699333059
   PubMed Web of Science ®Google Scholar
• LaurettiLRiccioMLMazzariolACloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolateAntimicrob Agents Chemother19994371584159010390207
   PubMed Web of Science ®Google Scholar
• PoirelLMagalhaesMLopesMNordmannPMolecular analysis of metallo-β-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, BrazilAntimicrob Agents Chemother20044841406140915047554
   PubMed Web of Science ®Google Scholar
• Rodríguez-MartínezJ-MPoirelLNordmannPExtended-spectrum cephalosporinases in Pseudomonas aeruginosaAntimicrob Agents Chemother20095351766177119258272
   PubMed Web of Science ®Google Scholar
• GirlichDNaasTNordmannPBiochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosaAntimicrob Agents Chemother20044862043204815155197
   PubMed Web of Science ®Google Scholar
• PoirelLNaasTNordmannPDiversity, epidemiology, and genetics of class D β-lactamasesAntimicrob Agents Chemother2010541243819721065
   PubMed Web of Science ®Google Scholar
• PhilipponLNNaasTBouthorsATBarakettVNordmannPOXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosaAntimicrob Agents Chemother19974110218821959333046
   PubMed Web of Science ®Google Scholar
• SevillanoEGallegoLGarcía-LoboJFirst detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumanniiPathol Biol (Paris)200957649349518585868
   PubMedGoogle Scholar
• El GarchFBogaertsPBebroneCGalleniMGlupczynskiYOXA-198, an acquired carbapenem-hydrolyzing class D β-lactamase from Pseudomonas aeruginosaAntimicrob Agents Chemother201155104828483321788473
   PubMed Web of Science ®Google Scholar
• HawkeyPFinchRTigecycline: in-vitro performance as a predictor of clinical efficacyClin Microbiol Infect200713435436217359318
   PubMed Web of Science ®Google Scholar
• SchwaberMJCarmeliYMortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysisJ Antimicrob Chemother200760591392017848376
   PubMed Web of Science ®Google Scholar
• NguyenMEschenauerGABryanMCarbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomesDiagn Microbiol Infect Dis201067218018420356699
   PubMed Web of Science ®Google Scholar
• QureshiZAPatersonDLPotoskiBATreatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimensAntimicrob Agents Chemother20125642108211322252816
   PubMed Web of Science ®Google Scholar
• DaikosGMarkogiannakisACarbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?Clin Microbiol Infect20111781135114121635663
   PubMed Web of Science ®Google Scholar